During the past decade, Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 94 clinical trials were completed, i.e. on average, 940% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 18 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 46 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "Saint Francis Care" with 16 trials sponsored, "National Cancer Institute (NCI)" with 15 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 103 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 52 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center" are "Breast Cancer" (22 trials), "Lung Cancer" (14 trials), "Lymphoma" (10 trials), "Pain" (10 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (8 trials). Many other conditions were trialed in "Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center" are "Drug" (110 trials), "Other" (52 trials), "Biological" (34 trials), "Procedure" (20 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (20 trials), "bevacizumab" (13 trials), "Placebo" (11 trials), "Laboratory Biomarker Analysis" (10 trials) and "carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center" are 126 trials for "All" genders, 27 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center". undefined are not yet recruiting, 3 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 120 completed trials in Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, 5 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 18 trials that are defined as “Not Applicable".

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center has several departments that took part in Clinical trials: "Mandell Center for Multiple Sclerosis at the Mount Sinai Rehabilitation Hospital" - 3 trials